MedPath

The Effect of Sihogayonggolmoryeo-tang on the Anxiety of Hwa-byung

Phase 4
Conditions
Hwa-byung
Interventions
Drug: SIHOGAYONGGOLMORYU TANG EXTRACT GRAN
Other: Placebo
Registration Number
NCT01362114
Lead Sponsor
Korea Health Industry Development Institute
Brief Summary

In this randomized, double blinded, Placebo-control Trial, the investigators planned to give Sihogayonggolmoryeo-tang extract or controlled medication on the Anxiety of Hwa-byung.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
160
Inclusion Criteria
  • male or female aged 20-65
  • subjects who meet structured interview criteria for Hwa-Byung Diagnosis
  • subjects who have axiety (more than 17 score in HAMA)
Exclusion Criteria
  • duration of illness less than 6 months
  • current or past history of delusions, hallucination
  • past history of at least one manic episode, hypomanic episode, or mixed episode
  • current or past history of alcohol abuse or alcohol dependence history
  • taking substances(e.g. steroids) which might affect symptoms
  • medical conditions(e.g. hyperthyroidism, hypothyroidism, heart disease) that might affect symptoms
  • current with hepatoma, hepatic cirrhosis, chronic renal failure, congestive heart failure
  • pregnancy, lactation, women not using medically accepted means of birth control
  • considered not apt to carry out clinical trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sihogayonggolmoryeo-tang extractSIHOGAYONGGOLMORYU TANG EXTRACT GRAN* name of product: 'SIHOGAYONGGOLMORYU TANG EXTRACT GRAN' * standard code for item: 200005676 * shape, type: extract(brown) * usage, content: adults;three times a day, each taken before or between meals * dose, standard: 2.5g for each sack, capsulated * storage : airtight container, stored in room temperature * expiration date : 36months after manufacture * macufacturing company: KyungBangnShinYak inc.
Placebo; corn flour,Placebo* raw material: total contents(500㎎); cornstarch 50.0%(250.0㎎), 당수화물 49.45%(247.25㎎), caramel pigment 0.5%(2.5㎎), SsangHwa fragrance 0.05%(0.25㎎) * shape, type: extract(brown) * usage, dose: adults: three times a day, 1 sack before or between meals * dose, standard: 2.5g for each sack, capsulated * storage : airtight container, stored in room temperature * expiration date : 36 months after manufacture * manufacturing company: KyungBangnShinYak inc.
Primary Outcome Measures
NameTimeMethod
Hamilton Anxiety Scale(HAM-A)8 weeks

The HAM-A (Hamilton Anxiety Scale) is a widely used interview scale that measures the severity of a patient's anxiety, based on 14 parameters, including anxious mood, tension, fears, insomnia, somatic complaints and behavior at the interview.

Secondary Outcome Measures
NameTimeMethod
State-Trait Anxiety Inventory(STAI)8 weeks

The State-Trait Anxiety Inventory (STAI) was initially conceptualized as a research instrument for the study of anxiety in adults. It is a self-report assessment device which includes separate measures of state and trait anxiety.

Beck Depression Inventory(BDI)8 weeks

BDI is a 21-question multiple-choice self-report inventory, one of the most widely used instruments for measuring the severity of depression. Each question has a set of at least four possible answer choices, ranging in intensity. When the test is scored, a value of 0 to 3 is assigned for each answer and then the total score is compared to a key to determine the depression's severity.

WHO Quality of Life Abbreviated(WHOQOL-BREF)8 weeks

Quality of life is used to evaluate the general well-being of individuals and societies.

Heart Rate Variability(HRV)8 weeks

Heart rate variability (HRV) is a physiological phenomenon where the time interval between heart beats varies. It is measured by the variation in the beat-to-beat interval.

likert scale8 weeks

This scale is used to evaluate the degree of Hwa-byung's major symptom by 5 point measure. (0,1,2,3,4)

Hwa-byung scale8 weeks

This scale is used for self report to evaluate the Hwa-byung's emotional symptoms, physical symptoms and personality traits by 5 point.(0,1,2,3,4).

State-Trait Anger Expression Inventory (STAXI)8 weeks

The State-Trait Anger Expression Inventory is a inventory which measures the intensity of anger as an emotional state (State Anger) and the disposition to experience angry feelings as a personality trait (Trait Anger). Items consist of 4-point scales that assess intensity of anger at a particular moment and the frequency of anger experience, expression, and control.

Insomnia Severity Index (ISI)8 weeks

The Insomnia Severity Index is a series of questions, seven in total, designed by medical professionals to help gauge the seriousness of a person's insomnia. The seven questions have numerical value, and the total is added up at the end of the process to give a total that symbolizes the seriousness of the problem

Instrument of Oriental Medical Evaluation for Hwa-Byung8 weeks

Instrument of Oriental Medical Evaluation for Hwa-Byung is a standard scale to evaluate for Oriental Medical cure in Hwa-Byung

Trial Locations

Locations (1)

Oriental Hospital of Daejon University

🇰🇷

Daejon, Choong-Chung-Do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath